Morphological cardiac alterations in liver cirrhosis: An autopsy study

被引:3
|
作者
Srinivasamurthy, Banushree Chandrasekhar [1 ]
Saravanan, Sanjay P. [1 ]
Marak, Fremingston K. [2 ]
Manivel, Prakash [3 ]
Bhat, Ramachandra, V [1 ]
Mathiyazhagan, Dharanya [1 ]
机构
[1] Indira Gandhi Med Coll & Res Inst, Dept Pathol, Pondicherry 605009, India
[2] Indira Gandhi Med Coll & Res Inst, Dept Forens Med, Pondicherry, India
[3] Indira Gandhi Med Coll & Res Inst, Dept Community Med, Pondicherry, India
来源
HEART VIEWS | 2021年 / 22卷 / 02期
关键词
Cardiomyopathy; cirrhosis; fibrosis; ventricular hypertrophy; CARDIOVASCULAR DYSFUNCTION; ALCOHOL-CONSUMPTION; PORTAL CIRRHOSIS; BINGE DRINKING; DISEASE; RISK; ATHEROSCLEROSIS; CALCIFICATION; HYPERTENSION;
D O I
10.4103/HEARTVIEWS.HEARTVIEWS_14_21
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Cirrhosis can cause various cardiac complications and severely affect the prognosis of the patient suffering from cirrhosis. Anatomical, morphological variations in the heart of patients with liver cirrhosis in the absence of known cardiac disease has not been well described. There is a paucity of studies in the literature on cardiac alterations in cirrhosis. Early detection of known cardiac alterations can further help in improving the quality of life.</p> & nbsp;</p> Materials and Methods: A cross-sectional descriptive study was conducted in the departments of pathology and forensic medicine of our institution. An autopsy-based prospective study of forty consecutive patients with final diagnosis of liver cirrhosis were included. Patients with a known history of cardiac disease/anomaly were excluded from the study. Macroscopic and microscopic changes in the heart and coronaries were noted and statistically analyzed.</p> & nbsp;</p> Results: Analysis of the hearts on gross examination showed cardiomegaly in 31 patients (77.5%). All cases had left ventricular hypertrophy. Endocardial thickening was seen in 22 patients (55%). Calcified mitral valve was seen in 9 patients (22.5%). On microscopy, apart from hypertrophy, the pathological changes like interstitial oedema (47.5%), fibrosis (45%), cardiac muscle disarray (87.5%), fatty infiltrate (10%), pericarditis (5%), and severe coronary artery atherosclerosis (17.5%) were seen in the patients.</p> & nbsp;</p> Conclusion: Knowledge about the involvement of the heart in liver cirrhosis is essential for both the physician and the surgeons to prevent adverse outcomes during liver transplantation and can further help in improving the quality of life of the patient.</p>
引用
收藏
页码:96 / 101
页数:6
相关论文
共 50 条
  • [1] Anatomical cardiac alterations in liver cirrhosis: An autopsy study
    Ortiz-Olvera, Nayeli X.
    Castellanos-Pallares, Guillermo
    Gomez-Jimenez, Luz M.
    Cabrera-Munoz, Maria L.
    Mendez-Navarro, Jorge
    Moran-Villota, Segundo
    Dehesa-Viotante, Margarita
    ANNALS OF HEPATOLOGY, 2011, 10 (03) : 321 - 326
  • [2] A STUDY OF CHANGES IN CARDIAC ECHOCARDIOGRAPHY IN CIRRHOSIS OF LIVER
    Jyotirmayi, Boddu
    Reddy, V. C. Srinivas
    JOURNAL OF EVOLUTION OF MEDICAL AND DENTAL SCIENCES-JEMDS, 2016, 5 (95): : 7019 - 7021
  • [3] Association of type 2 diabetes with liver cirrhosis: a nationwide cohort study
    Hsieh, Ping-Hsin
    Huang, Jing-Yang
    Nfor, Oswald Ndi
    Lung, Chia-Chi
    Ho, Chien-Chang
    Liaw, Yung-Po
    ONCOTARGET, 2017, 8 (46) : 81321 - 81328
  • [4] Histomorphological features of pancreas and liver in chronic alcoholics - an analytical study in 390 autopsy cases
    Agrawal, Pallavi
    Vaiphei, Kim
    INDIAN JOURNAL OF PATHOLOGY AND MICROBIOLOGY, 2014, 57 (01) : 2 - 8
  • [5] Markers of cardiac injury in patients with liver cirrhosis
    Simic, Stjepan
    Svagusa, Tomo
    Grgurevic, Ivica
    Mustapic, Sanda
    Zarak, Marko
    Prkacin, Ingrid
    CROATIAN MEDICAL JOURNAL, 2023, 64 (05) : 362 - 373
  • [6] Cardiac and systemic haemodynamic complications of liver cirrhosis
    Henriksen, Jens H.
    Moller, Soren
    SCANDINAVIAN CARDIOVASCULAR JOURNAL, 2009, 43 (04) : 218 - 225
  • [7] Morphological cardiac alterations in drug deaths
    Roehr, W.
    Corvest, E.
    Gaul, D. S.
    Bratzke, H.
    Verhoff, M. A.
    Petzel-Witt, S.
    Niess, C.
    Kauferstein, S.
    RECHTSMEDIZIN, 2024, 34 (06) : 417 - 424
  • [8] Brain Natriuretic Peptide in Decompensation of Liver Cirrhosis in Non-cardiac Patients
    Radvan, Martin
    Svoboda, Petr
    Radvanova, Jana
    Stumar, Josef
    Scheer, Peter
    HEPATO-GASTROENTEROLOGY, 2009, 56 (89) : 181 - 185
  • [9] Alterations of Bone Marrow Sinusoidal Endothelium in Rat and Patients with Liver Cirrhosis
    Zhao, Song
    Fu, Ying-Mei
    Li, Xiu-Fen
    Jin, Zhan-Feng
    Zhao, Rui-Bo
    Huang, Qi
    Zhang, Feng-Min
    Zhang, Wei-Hui
    DIGESTIVE DISEASES AND SCIENCES, 2010, 55 (03) : 654 - 661
  • [10] Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis
    Wu, Zengrong
    Zhou, Hejun
    Liu, Deliang
    Deng, Feihong
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2023, 13